Galapagos N.V.
Galapagos N.V. (GLPGF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · GLPGF · as of Jun 8, 2026
Key Statistics
Explore Galapagos N.V. Data
glpgf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 16 · Buy rate: 18.8%
Competitors & Peers
glpgf competitorsGLPGF
ANSLY
BVNKF
BVNRY
MAHLY
ONTTFStock Performance
Full HistoryAbout Galapagos N.V.
Galapagos N.V. is a fully-integrated biopharmaceutical firm dedicated to discovering, developing, and bringing to market innovative therapies for conditions where patient needs are largely unaddressed…
what is galapagos n.v. · glpgf stock overview · galapagos n.v. company profile · who is galapagos n.v. ceo · glpgf OTC · galapagos n.v. headquarters · galapagos n.v. business segments
About Stock Overview & Key Data
Galapagos N.V. (GLPGF) is a Healthcare company in the Biotechnology industry, listed on OTC since Aug 3, 2009. As of the latest trading session, GLPGF stock price is $28.08, with a market capitalization of $1.9B. The stock has returned +2.11% over the past 12 months and -10.26% year-to-date.
According to 16 Wall Street analysts, the consensus rating for Galapagos N.V. stock is Hold, with an average 12-month price target of $—. In fiscal year 2025, Galapagos N.V. reported revenue of $1.1B and net income of $320.8M. For detailed data — including Galapagos N.V. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Galapagos N.V. (GLPGF) stock price is $28.08. The stock is traded on OTC under the ticker symbol GLPGF. The 52-week range is $22.39 – $48.70.